These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26882440)

  • 1. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
    Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
    Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells.
    Aguilar-Chaparro MA; Rivera-Pineda SA; Hernández-Galdámez HV; Piña-Vázquez C; Villa-Treviño S
    Stem Cell Res; 2023 Oct; 72():103222. PubMed ID: 37844417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.
    Kakehashi A; Stefanov VE; Ishii N; Okuno T; Fujii H; Kawai K; Kawada N; Wanibuchi H
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
    Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
    Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
    Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
    Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
    Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
    Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality.
    Hagiwara M; Kikuchi E; Kosaka T; Mikami S; Saya H; Oya M
    Urol Oncol; 2016 Aug; 34(8):337.e19-26. PubMed ID: 27133224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
    Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
    Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.
    Sakabe T; Azumi J; Umekita Y; Toriguchi K; Hatano E; Hirooka Y; Shiota G
    Liver Int; 2017 Feb; 37(2):271-279. PubMed ID: 27473646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer.
    Go SI; Ko GH; Lee WS; Lee JH; Jeong SH; Lee YJ; Hong SC; Ha WS
    Cancer Res Treat; 2019 Oct; 51(4):1411-1419. PubMed ID: 30913874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells.
    Tsugawa H; Kato C; Mori H; Matsuzaki J; Kameyama K; Saya H; Hatakeyama M; Suematsu M; Suzuki H
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):319-334. PubMed ID: 31146068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma.
    Chen J; Yu Y; Ji T; Ma R; Chen M; Li G; Li F; Ding Q; Kang Q; Huang D; Liang X; Lin H; Cai X
    Cancer Med; 2016 Oct; 5(10):2678-2687. PubMed ID: 27650414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.
    Wada F; Koga H; Akiba J; Niizeki T; Iwamoto H; Ikezono Y; Nakamura T; Abe M; Masuda A; Sakaue T; Tanaka T; Kakuma T; Yano H; Torimura T
    Cancer Sci; 2018 Sep; 109(9):2801-2810. PubMed ID: 29981246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation.
    Mizuochi S; Akiba J; Kondo R; Kusano H; Shioga T; Kondo K; Tsutsui K; Nakayama M; Ogasawara S; Naito Y; Nakashima O; Yano H
    Anticancer Res; 2022 Jan; 42(1):449-457. PubMed ID: 34969755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.